Clinical Trial Update: A Study of Radiation Therapy and Cemiplimab With or Without Fianlimab In People With Bladder Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating radiation therapy with cemiplimab, with or without fianlimab, in bladder urothelial carcinoma. The study status indicates it is not y…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Urothelial Carcinoma

Drugs mentioned

• Cemiplimab (cemiplimab)
• Fianlimab (fianlimab)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Bladder Urothelial Carcinoma | Phase 2 | Status: NOT_YET_RECRUITING